Literature DB >> 7310140

A new radioimmunoassay for IgM and IgG rheumatoid factors, based on a double antibody method.

O Nordfang, M Høier-Madsen, P Halberg, J Lieberkind.   

Abstract

A new radioimmunoassay has been developed for measuring IgM and IgG rheumatoid factors. Diluted sera from donors and patients were incubated with immunoprecipitates prepared from sheep serum and rabbit anti-sheep IgG antiserum. The precipitates were washed, and radioiodinated rabbit F(ab')2 fragments specific from human IgM or IgG were added. The precipitates were isolated from filtration and measured in a gamma counter. With this assay IgM rheumatoid factors were detected in sera from all patients with seropositive rheumatoid arthritis and in sera from 40% of patients with seronegative rheumatoid arthritis. IgG rheumatoid factors were found in sera from 68% of the seropositive and 40% of the seronegative patients. Gel filtration experiments demonstrated that it is possible to detect monomeric IgG rheumatoid factors and IgM rheumatoid factors of molecular weight smaller than pentameric IgM. Furthermore it has been shown that IgG rheumatoid factor activity is still present after reduction of IgM rheumatoid factors with dithiothreitol.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7310140     DOI: 10.1016/0022-1759(81)90259-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  6 in total

1.  Clinical value of ELISA assays for IgM and IgG rheumatoid factors.

Authors:  R Stone; J S Coppock; P T Dawes; P A Bacon; D L Scott
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

2.  Serum amino terminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis: relation to clinical and serological parameters of inflammation during 8 and 24 months' treatment with levamisole, penicillamine, or azathioprine.

Authors:  K Hørslev-Petersen; K D Bentsen; A Engström-Laurent; P Junker; P Halberg; I Lorenzen
Journal:  Ann Rheum Dis       Date:  1988-02       Impact factor: 19.103

3.  Measurement of rheumatoid factors by an enzyme-linked immunosorbent assay (ELISA) and comparison with other methods.

Authors:  J L Bampton; T E Cawston; M V Kyle; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1985-01       Impact factor: 19.103

4.  Rheumatoid factor (RF) distribution in periodontal disease.

Authors:  J Thé; J L Ebersole
Journal:  J Clin Immunol       Date:  1991-05       Impact factor: 8.317

5.  Influence of previous gold treatment and other patient variables on outcome of treatment with disease modifying anti-rheumatic drugs (DMARD) in patients with rheumatoid arthritis.

Authors:  M W Bentzon; I Gad; P Halberg; O Halskov; B K Jacobsen; I Lorenzen; N Morling; A Svejgaard
Journal:  Clin Rheumatol       Date:  1986-01       Impact factor: 2.980

6.  ELISA assays for IgM and IgG rheumatoid factors: their clinical correlations during therapy with slow-acting anti-rheumatic drugs.

Authors:  D L Scott; P T Dawes; M Collins; R Stone
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.